LIDOcaine HCl 2% 100 mg/ Fill in a Single Dose Syringe recalled over sterility concerns
- Recall date
- September 12, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- KRS Global Biotechnology, Inc recalls LIDOcaine HCl 2% (PF) 100 mg/5 mL (20 mg/mL) 5 mL Fill in a 6 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology…
- Recall number
- D-0069-2020
- FDA classification
- Class II
- Brand / firm
- KRS Global Biotechnology, Inc
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
LIDOcaine HCl 2% (PF) 100 mg/5 mL (20 mg/mL) 5 mL Fill in a 6 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487NDC 3321678315
Get recall alerts
Free email alert whenever KRS Global Biotechnology, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: KRS Global Biotechnology, Inc